Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin.
Raccah D, Chou E, Colagiuri S, Gaàl Z, Lavalle F, Mkrtumyan A, Nikonova E, Tentolouris N, Vidal J, Davies M. Raccah D, et al. Among authors: gaal z. Diabetes Metab Res Rev. 2017 Mar;33(3):e2858. doi: 10.1002/dmrr.2858. Epub 2016 Oct 13. Diabetes Metab Res Rev. 2017. PMID: 27606888 Free PMC article.
Improved glycemic control through continuous glucose sensor-augmented insulin pump therapy: prospective results from a community and academic practice patient registry.
Cohen O, Körner A, Chlup R, Zoupas CS, Ragozin AK, Wudi K, Bartaskova D, Pappas A, Niederland T, Taybani Z, Barák L, Vazeou A; Central and Eastern Europe, Greece, and Israel Continuous Glucose Sensing Collaborative Study Group. Cohen O, et al. J Diabetes Sci Technol. 2009 Jul 1;3(4):804-11. doi: 10.1177/193229680900300429. J Diabetes Sci Technol. 2009. PMID: 20144331 Free PMC article.
[Evaluation of the DIABOBHU Observational Study].
Gaál Z, Papp Z, Bakó B. Gaál Z, et al. Orv Hetil. 2014 Jun 8;155(23):903-10. doi: 10.1556/OH.2014.29927. Orv Hetil. 2014. PMID: 24880969 Clinical Trial. Hungarian.
Cardiovascular risk factors characteristic for the metabolic syndrome in adult patients with type 1 diabetes.
Nádas J, Putz Z, Fövényi J, Gaál Z, Gyimesi A, Hídvégi T, Hosszúfalusi N, Neuwirth G, Oroszlán T, Pánczél P, Széles G, Vándorfi G, Winkler G, Wittmann I, Jermendy G. Nádas J, et al. Among authors: gaal z. Exp Clin Endocrinol Diabetes. 2009 Mar;117(3):107-12. doi: 10.1055/s-0028-1082068. Epub 2009 Mar 10. Exp Clin Endocrinol Diabetes. 2009. PMID: 19277931
Monogenic Forms of Diabetes Mellitus.
Gaál Z, Balogh I. Gaál Z, et al. Exp Suppl. 2019;111:385-416. doi: 10.1007/978-3-030-25905-1_18. Exp Suppl. 2019. PMID: 31588541 Review.
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Cardiometabolic risk and educational level in adult patients with type 1 diabetes.
Nádas J, Putz Z, Fövényi J, Gaál Z, Gyimesi A, Hídvégi T, Hosszúfalusi N, Neuwirth G, Oroszlán T, Pánczél P, Vándorfi G, Winkler G, Wittmann I, Jermendy G. Nádas J, et al. Among authors: gaal z. Acta Diabetol. 2009 Jun;46(2):159-62. doi: 10.1007/s00592-008-0065-4. Epub 2008 Oct 9. Acta Diabetol. 2009. PMID: 18843447
81 results